Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Paratek Pharmaceuticals
Pharma
Paratek's pneumonia antibiotic Nuzyra clinches trial win
Paratek, which was bought out by Novo Holdings and Gurnet Point Capital last year, plans to speak with the FDA about a Nuzyra label update in CABP.
Zoey Becker
Jul 19, 2024 8:28am
Paratek's $462M sale under threat from investor NexPoint
Jun 28, 2023 2:03pm
Paratek bought by Novo Holdings, Gurnet Point for $462M
Jun 6, 2023 4:21pm
What will become of Trump's 'onshore' drug production effort?
Dec 22, 2020 3:00am
Michigan CDMO builds new plant to meet U.S.-made drug demand
Jun 30, 2020 9:00am
Former BMS site marketed as the new home for 'onshoring' pharmas
Jun 22, 2020 4:28pm